Park S, Ryu W, Kim T, Hwang Y, Han H, Lee J
Exp Mol Med. 2024; 56(4):987-1000.
PMID: 38622197
PMC: 11059244.
DOI: 10.1038/s12276-024-01210-5.
Mondru A, Aljasir M, Alrumayh A, Nithianandarajah G, Ahmed K, Muller J
Cells. 2023; 12(6).
PMID: 36980305
PMC: 10047687.
DOI: 10.3390/cells12060967.
Perrelli A, Ferraris C, Berni E, Glading A, Retta S
Antioxid Redox Signal. 2022; 38(7-9):496-528.
PMID: 36047808
PMC: 10039281.
DOI: 10.1089/ars.2021.0263.
Yang Y, Mumau M, Tober J, Zhu Q, Bennett L, Hong C
Blood. 2022; 139(19):2942-2957.
PMID: 35245372
PMC: 9101247.
DOI: 10.1182/blood.2021013934.
Takemoto G, Matsushita M, Okamoto T, Ito T, Matsuura Y, Takashima C
Front Cell Dev Biol. 2022; 9:694018.
PMID: 35118060
PMC: 8804316.
DOI: 10.3389/fcell.2021.694018.
Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.
Monti M, Celli J, Missale F, Cersosimo F, Russo M, Belloni E
Cancers (Basel). 2022; 14(2).
PMID: 35053510
PMC: 8773716.
DOI: 10.3390/cancers14020348.
MEKK3-TGFβ crosstalk regulates inward arterial remodeling.
Deng H, Xu Y, Hu X, Zhuang Z, Chang Y, Wang Y
Proc Natl Acad Sci U S A. 2021; 118(51).
PMID: 34911761
PMC: 8713777.
DOI: 10.1073/pnas.2112625118.
ERK/MAPK signalling pathway and tumorigenesis.
Guo Y, Pan W, Liu S, Shen Z, Xu Y, Hu L
Exp Ther Med. 2020; 19(3):1997-2007.
PMID: 32104259
PMC: 7027163.
DOI: 10.3892/etm.2020.8454.
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.
Tubita A, Lombardi Z, Tusa I, Dello Sbarba P, Rovida E
Int J Mol Sci. 2020; 21(3).
PMID: 32023850
PMC: 7038028.
DOI: 10.3390/ijms21030938.
Targeting MEK5 impairs nonhomologous end-joining repair and sensitizes prostate cancer to DNA damaging agents.
Broustas C, Duval A, Chaudhary K, Friedman R, Virk R, Lieberman H
Oncogene. 2020; 39(12):2467-2477.
PMID: 31980741
PMC: 7085449.
DOI: 10.1038/s41388-020-1163-1.
Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer.
Olea-Flores M, Zuniga-Eulogio M, Mendoza-Catalan M, Rodriguez-Ruiz H, Castaneda-Saucedo E, Ortuno-Pineda C
Int J Mol Sci. 2019; 20(12).
PMID: 31200510
PMC: 6627365.
DOI: 10.3390/ijms20122885.
IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1 stem cells.
Chen X, Cai G, Liu C, Zhao J, Gu C, Wu L
J Exp Med. 2018; 216(1):195-214.
PMID: 30578323
PMC: 6314525.
DOI: 10.1084/jem.20171849.
IFN-γ-inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5.
Saleiro D, Blyth G, Kosciuczuk E, Ozark P, Majchrzak-Kita B, Arslan A
Sci Signal. 2018; 11(557).
PMID: 30459284
PMC: 6684240.
DOI: 10.1126/scisignal.aap9921.
Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice.
Fan X, Wang C, Shi P, Gao W, Gu J, Geng Y
Blood Adv. 2018; 2(12):1439-1448.
PMID: 29941457
PMC: 6020810.
DOI: 10.1182/bloodadvances.2017015149.
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S, Meyer-Schaller N, Diepenbruck M, Kalathur R, Saxena M, Christofori G
Oncogene. 2018; 37(31):4197-4213.
PMID: 29713055
DOI: 10.1038/s41388-018-0270-8.
MEF2 transcription factors in human placenta and involvement in cytotrophoblast invasion and differentiation.
Li L, Rubin L, Gong X
Physiol Genomics. 2017; 50(1):10-19.
PMID: 29127222
PMC: 5866412.
DOI: 10.1152/physiolgenomics.00076.2017.
Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cells.
Wilkinson E, Sidaway J, Cross M
J Cell Physiol. 2017; 233(1):186-200.
PMID: 28639275
PMC: 5655747.
DOI: 10.1002/jcp.26064.
Oncogenic signaling of MEK5-ERK5.
Hoang V, Yan T, Cavanaugh J, Flaherty P, Beckman B, Burow M
Cancer Lett. 2017; 392:51-59.
PMID: 28153789
PMC: 5901897.
DOI: 10.1016/j.canlet.2017.01.034.
A novel function for the MAP kinase SMA-5 in intestinal tube stability.
Geisler F, Gerhardus H, Carberry K, Davis W, Jorgensen E, Richardson C
Mol Biol Cell. 2016; 27(24):3855-3868.
PMID: 27733627
PMC: 5170608.
DOI: 10.1091/mbc.E16-02-0099.
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
Zhou Z, Tang A, Wong W, Bamezai S, Goddard L, Shenkar R
Nature. 2016; 532(7597):122-6.
PMID: 27027284
PMC: 4864035.
DOI: 10.1038/nature17178.